TICKER INTELLIGENCE
Akamai Technologies, Inc. ($AKAM)
NYSE/NASDAQ: AKAM
Washington Intelligence
0
Active Bills
0
Gov't Contracts
34
Congressional Trades
$AKAM is a publicly traded company in the various sectors sector. This company operates across various sectors and is subject to various Congressional legislative and regulatory actions. HillSignal monitors Congressional activity for signals mentioning $AKAM. No active signals are currently tracked.
Active Monitoring
Congressional members have traded $AKAM in 34 filings. HillSignal is actively monitoring for related legislation, federal contracts, and executive actions. New signals will appear here automatically when detected.
Congressional Trades in $AKAM
34 filings⚠ ⚠️ PRESIDENTIAL ACTION: Presidential Memorandum signed 7/30/2026: "Presidential Determination Pursuant to Section 101 of the Defense Production Act of 1950, as Amended". This DPA action will boost investment and production in domestic critical mineral recycling and processing, likely increasing stock valuations for pure-play recovery companies and defense contractors reliant on secure rare-earth magnet supplies, while potentially raising costs for import-dependent manufacturers.
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ Josh Gottheimer sold $1,001 - $15,000 in PFE on 2025-06-03, 2 days before the 'Treat and Reduce Obesity Act of 2025' (S1973) was introduced, which aims to expand Medicare coverage for obesity treatments.
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ Representative Shreve bought $15,001 - $50,000 in AMGN on February 24, 2025 — 8 days before the EPIC Act of 2025 (S832) was introduced, which proposes to extend market exclusivity for small-molecule drugs.
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
Understanding These Signals
Get Full Access to Akamai Technologies, Inc. ($AKAM) Signals
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Get Started →